相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
Miwako Kobayashi et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age
Donald Hurley et al.
CLINICAL INFECTIOUS DISEASES (2021)
Serotype Patterns of Pneumococcal Disease in Adults Are Correlated With Carriage Patterns in Older Children
Anne L. Wyllie et al.
CLINICAL INFECTIOUS DISEASES (2021)
Distribution and Variation of Serotypes and Pneumococcal Surface Protein A Clades of Streptococcus pneumoniae Strains Isolated From Adult Patients With Invasive Pneumococcal Disease in Japan
Bin Chang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Streptococcus pneumoniae binds to host GAPDH on dying lung epithelial cells worsening secondary infection following influenza
Sang-Sang Park et al.
CELL REPORTS (2021)
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults
Helen L. Stacey et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study
Shamez N. Ladhani et al.
LANCET INFECTIOUS DISEASES (2018)
Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil
Maria-Cristina C. Brandileone et al.
VACCINE (2018)
Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci
Taj Azarian et al.
PLOS PATHOGENS (2018)
GTL001, a bivalent therapeutic vaccine against human papillomavirus 16 and 18, induces antigen-specific CD8+ T cell responses leading to tumor regression
Michael Esquerre et al.
PLOS ONE (2017)
Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae
Rafaella O. Tostes et al.
PLOS ONE (2017)
Optimized Triton X-114 assisted lipopolysaccharide (LPS) removal method reveals the immunomodulatory effect of food proteins
Malgorzata Teodorowicz et al.
PLOS ONE (2017)
Th17-Mediated Cross Protection against Pneumococcal Carriage by Vaccination with a Variable Antigen
Kirsten Kuipers et al.
INFECTION AND IMMUNITY (2017)
GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial
Pierre Van Damme et al.
CLINICAL CANCER RESEARCH (2016)
Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015
Ravinder Kaur et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2016)
Molecular surveillance on Streptococcus pneumoniae carriage in non-elderly adults; little evidence for pneumococcal circulation independent from the reservoir in children
Anne L. Wyllie et al.
SCIENTIFIC REPORTS (2016)
Pertussis Toxin Improves Immune Responses to a Combined Pneumococcal Antigen and Leads to Enhanced Protection against Streptococcus pneumoniae
Carolina Salcedo-Rivillas et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Mapping of Epitopes Recognized by Antibodies Induced by Immunization of Mice with PspA and PspC
Cintia F. M. Vadesilho et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Bordetella pertussis pathogenesis: current and future challenges
Jeffrey A. Melvin et al.
NATURE REVIEWS MICROBIOLOGY (2014)
Serotype-independent pneumococcal vaccines
Eliane Namie Miyaji et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Controlled Inflammatory Responses in the Lungs Are Associated with Protection Elicited by a Pneumococcal Surface Protein A-Based Vaccine against a Lethal Respiratory Challenge with Streptococcus pneumoniae in Mice
Fernanda A. Lima et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Pneumococcal Surface Protein A Inhibits Complement Deposition on the Pneumococcal Surface by Competing with the Binding of C-Reactive Protein to Cell-Surface Phosphocholine
Reshmi Mukerji et al.
JOURNAL OF IMMUNOLOGY (2012)
The Nasal Dendritic Cell-Targeting Flt3 Ligand as a Safe Adjuvant Elicits Effective Protection against Fatal Pneumococcal Pneumonia
Kosuke Kataoka et al.
INFECTION AND IMMUNITY (2011)
Serotype replacement in disease after pneumococcal vaccination
Daniel M. Weinberger et al.
LANCET (2011)
Immunization of Mice with Single PspA Fragments Induces Antibodies Capable of Mediating Complement Deposition on Different Pneumococcal Strains and Cross-Protection
Adriana T. Moreno et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Combination of Pneumococcal Surface Protein A (PspA) with Whole Cell Pertussis Vaccine Increases Protection Against Pneumococcal Challenge in Mice
Maria Leonor S. Oliveira et al.
PLOS ONE (2010)
Enzymatic assembly of DNA molecules up to several hundred kilobases
Daniel G. Gibson et al.
NATURE METHODS (2009)
Comparison of the pulmonary response against lethal and non-lethal intranasal challenges with two different pneumococcal strains
Daniela M. Ferreira et al.
MICROBIAL PATHOGENESIS (2009)
Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production
Daniela M. Ferreira et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades
Michelle Darrieux et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Genetic diversity of PspA types among nasopharyngeal isolates collected during an ongoing surveillance study of children in Brazil
Fabiana Cristina Pimenta et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults
L. Baril et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Delivery of the HIV-1 Tat protein to dendritic cells by the CyaA vector induces specific Th1 responses and high affinity neutralizing antibodies in non human primates
L Mascarell et al.
VACCINE (2006)
Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries
SK Hollingshead et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-Cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis
L Mascarell et al.
JOURNAL OF VIROLOGY (2005)
PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin
M Shaper et al.
INFECTION AND IMMUNITY (2004)
A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal his-tagged fusion peptide
CRR Ramos et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2004)
Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens
J MacDonald-Fyall et al.
VACCINE (2004)
Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model
H Roche et al.
INFECTION AND IMMUNITY (2003)
Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae
B Ren et al.
INFECTION AND IMMUNITY (2003)
Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection
BP Arulanandam et al.
INFECTION AND IMMUNITY (2001)
Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA
DE Briles et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Diversity of PspA:: Mosaic genes and evidence for past recombination in Streptococcus pneumoniae
SK Hollingshead et al.
INFECTION AND IMMUNITY (2000)
Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules
GS Nabors et al.
VACCINE (2000)
分享论文
